Task: Answer the multiple choice question.
Question: Which compound exhibits a -57.012% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
[a] CC1CCN(C(=O)CCC(=O)Nc2nnc(C3CCCCC3)s2)CC1
[b] CCCCN(CC)C(=O)Cn1cnc2ccc(S(=O)(=O)N3CCC(C)CC3)cc2c1=O
[c] COc1cccc(C(=O)NCCS(=O)(=O)N2CC(C)CC(C)C2)c1
[d] COc1ccc(C(=O)Oc2ccc3ccc(=O)oc3c2)cc1
[e] Cc1cccc(-n2ncc3c(NCc4cccs4)ncnc32)c1
Answer: b. CCCCN(CC)C(=O)Cn1cnc2ccc(S(=O)(=O)N3CCC(C)CC3)cc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(CC)C(=O)Cn1cnc2ccc(S(=O)(=O)N3CCC(C)CC3)cc2c1=O
CCCCN(CC)C(=O)Cn1cnc2ccc(S(=O)(=O)N3CCC(C)CC3)cc2c1=O
N-butyl-N-ethyl-2-[6-(4-methylpiperidin-1-yl)sulfonyl-4-oxoquinazolin-3-yl]acetamide